Literature DB >> 11462922

Liver hemangioma revisited: current surgical indications, technical aspects, results.

I Popescu1, S Ciurea, V Brasoveanu, D Hrehoret, P Boeti, S Georgescu, D Tulbure.   

Abstract

BACKGROUND/AIMS: New developments regarding the diagnosis of liver hemangiomas, surgical indication and therapeutic options emerged recently. We reviewed our experience from the point of view of these modern developments.
METHODOLOGY: Fifty-seven patients with liver hemangiomas were retrospectively studied. The relationship between size, symptoms and treatment was assessed.
RESULTS: Indication for surgery was the size of the lesion in 5 patients, symptomatology in 48 and uncertain diagnosis in 4. Increase in size was noted in four patients. Six patients had associated intraabdominal benign or malignant pathology. The treatment of choice was enucleation. Postoperative complications were noted in 6 patients and mortality was nil. In 3 patients the hemangiomas recurred and were reresected in 2.
CONCLUSIONS: Hemangiomas should be resected when larger than 10 cm and when they become symptomatic. With the modern diagnostic work-up, uncertainty of diagnosis as an indication for surgery should be rare. Surgery remains the main treatment, with a low morbidity and mortality if performed in a specialized hepatobiliary unit. Enucleation is the surgical option of choice. In selected cases laparoscopic enucleation can be performed with good results.

Entities:  

Mesh:

Year:  2001        PMID: 11462922

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Defining perioperative risk after hepatectomy based on diagnosis and extent of resection.

Authors:  Christopher R Shubert; Elizabeth B Habermann; Mark J Truty; Kristine M Thomsen; Michael L Kendrick; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2014-09-09       Impact factor: 3.452

2.  Preoperative arterial embolization of large liver hemangiomas.

Authors:  Serdar Topaloğlu; Şükrü Oğuz; Orhan Kalaycı; M Halil Öztürk; Adnan Çalık; Hasan Dinç; Ümit Çobanoğlu
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

3.  Surgical treatment of giant liver hemangiomas: enucleation with continuous occlusion of hepatic artery proper and intermittent Pringle maneuver.

Authors:  Feng Xia; Wan-Yee Lau; Cheng Qian; Shuguang Wang; Kuansheng Ma; Ping Bie
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

4.  Laparoscopic resection of a giant exophytic liver haemangioma with the laparoscopic Habib 4× radiofrequency device.

Authors:  Metesh Acharya; Nikolaos Panagiotopoulos; Premjithlal Bhaskaran; Charis Kyriakides; Madhava Pai; Nagy Habib
Journal:  World J Gastrointest Surg       Date:  2012-08-27

5.  Surgical Management of Giant Hepatic Hemangioma: Single Center's Experience with 144 Patients.

Authors:  Mohamed Abdel Wahab; Ayman El Nakeeb; Mahmoud Abdelwahab Ali; Youssef Mahdy; Ahmed Shehta; Mohamed Abdulrazek; Mohamed El Desoky; Rihame Abdel Wahab
Journal:  J Gastrointest Surg       Date:  2018-02-27       Impact factor: 3.452

6.  Giant haemangioma of the liver: is enucleation better than resection?

Authors:  Rajneesh Kumar Singh; Sorabh Kapoor; Peush Sahni; Tushar K Chattopadhyay
Journal:  Ann R Coll Surg Engl       Date:  2007-07       Impact factor: 1.891

Review 7.  Elective surgery for benign liver tumours.

Authors:  A Colli; M Fraquelli; S Massironi; A Colucci; S Paggi; D Conte
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

8.  Obstructive jaundice caused by a giant liver hemangioma with Kasabach-Merritt syndrome: a case report.

Authors:  Takuya Yano; Tsuyoshi Kobayashi; Shintaro Kuroda; Hironobu Amano; Hirotaka Tashiro; Hideki Ohdan
Journal:  Surg Case Rep       Date:  2015-10-06

9.  Surgical Treatment of Giant Liver Hemangioma Larger Than 10 cm: A Single Center's Experience With 86 Patients.

Authors:  Wei Zhang; Zhi-Yong Huang; Chang-Shu Ke; Chao Wu; Zhi-Wei Zhang; Bi-Xiang Zhang; Yi-Fa Chen; Wan-Guang Zhang; Peng Zhu; Xiao-Ping Chen
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.